PCN98 IMPACT OF RECENT ERYTHROPOIESIS-STIMULATING AGENT (ESA) POLICY CHANGES ON DOSING PATTERNS IN CANCER CHEMOTHERAPY PATIENTS
May 1, 2009, 00:00 AM
10.1016/S1098-3015(10)73335-0
https://www.valueinhealthjournal.com/article/S1098-3015(10)73335-0/fulltext
Section Title :
Section Order :
763
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)73335-0&doi=10.1016/S1098-3015(10)73335-0